# Sermorelin vs MK-677: Key Differences & Which to Consider **By TelosRX Editorial Team** · 2026-08-23 **Sermorelin vs MK-677 is one of the most common questions in growth hormone support: both stimulate your body's own GH production but work through entirely different mechanisms and routes. [TelosRX](https://telosrx.com) offers asynchronous provider evaluation for compounded peptide protocols, subject to medical approval by a licensed provider.** Neither compound is FDA-approved. The right choice between them depends on your goals, your tolerance for injections, and your specific hormonal picture — not a general preference. Here's what the research actually distinguishes between them. ## What Is Sermorelin? Sermorelin is a synthetic 29-amino-acid peptide that mimics growth hormone-releasing hormone (GHRH). It binds GHRH receptors in the pituitary gland and triggers a pulse of natural growth hormone (GH) release — the same signal your body produces on its own. Originally developed as a diagnostic agent and studied in adult GH deficiency, sermorelin is now compounded and used off-label for age-related GH decline. It is not FDA-approved for these uses and is available only through a licensed prescriber after individual evaluation. See our [sermorelin research guide](https://www.telosrx.com/blogs/hormone-longevity/sermorelin-growth-hormone-peptide-research-guide) for the full evidence overview. ## What Is MK-677 (Ibutamoren)? MK-677, also called ibutamoren, is technically not a peptide. It's a non-peptide small molecule that mimics ghrelin — the "hunger hormone" — by binding the ghrelin receptor in the pituitary. That receptor also controls GH release, so MK-677 raises GH through a different pathway than sermorelin. The practical result: it's an oral capsule taken once daily rather than a subcutaneous injection. Originally developed by Merck in the 1990s, MK-677 remains investigational and is not FDA-approved. Our [MK-677 overview](https://www.telosrx.com/blogs/peptides/mk-677-ibutamoren-growth-hormone-secretagogue) covers the mechanism and available research in detail. ## Sermorelin vs MK-677: Head-to-Head Comparison Factor Sermorelin MK-677 (Ibutamoren) Compound type Synthetic peptide (GHRH analog) Non-peptide small molecule Administration Subcutaneous injection Oral capsule Mechanism GHRH receptor agonist Ghrelin receptor agonist GH release pattern Pulsatile, mimics natural rhythm Sustained elevation Half-life ~10–20 minutes ~24 hours Appetite effect Minimal Increased (ghrelin mimetic) Sleep quality benefit Strong — aligns with natural GH sleep peak Present, especially early IGF-1 elevation Moderate, pulsatile Sustained; often higher over 24 hours Regulatory status Compounded; not FDA-approved Investigational; not FDA-approved ## Mechanism: Why the Difference Matters **Sermorelin** works upstream of GH itself. It signals your pituitary to release GH in pulses that follow your natural circadian GH rhythm — highest during deep sleep, lower during the day. A 2020 review in [_Translational Andrology and Urology_](https://tau.amegroups.org/article/view/33160/28655) confirmed that sermorelin produces GH changes comparable to endogenous GHRH, supporting its physiological relevance as a secretagogue. **MK-677** binds the ghrelin receptor — the same receptor that drives hunger — which also happens to control GH release from the pituitary. Because ghrelin receptor signaling is continuous rather than pulsatile, MK-677 produces a more sustained GH elevation over 24 hours. A two-year randomized trial documented in [PubMed](https://pubmed.ncbi.nlm.nih.gov/9467543/) confirmed sustained IGF-1 elevation and improved body composition with daily oral dosing. That sustained elevation drives higher average IGF-1 levels but departs from the pulsatile pattern your body uses naturally. Neither approach is simply "better" — pulsatile vs. sustained matters differently depending on your goals. ## Administration, Dosing, and Monitoring Sermorelin is injected subcutaneously, usually at bedtime to align with natural sleep-phase GH release. Most people find the injection simple to administer. Dose and duration are set by the prescribing provider. MK-677 is an oral once-daily capsule, usually taken in the evening. No injection technique required. This makes it the default choice for patients who won't use injectables. Both compounds require periodic IGF-1 monitoring to ensure GH stimulation stays within physiological range. If you're on other hormone protocols, review our [hormone optimization protocol guide](https://www.telosrx.com/blogs/hormone-longevity/hormone-optimization-protocol-step-by-step-guide) to understand how growth hormone support fits into a broader plan. ## Side Effects to Know - **Sermorelin:** Injection-site irritation, headache, facial flushing, and — at supraphysiological doses — water retention or joint discomfort from excess GH stimulation. - **MK-677:** Notably increased appetite (often significant and unwanted), water retention, transient elevations in fasting glucose, and fatigue at higher doses. Long-term safety data in humans is limited. Neither compound should be used without provider-level oversight. Individuals with a history of cancer, active pituitary disorders, or elevated IGF-1 at baseline are generally not candidates for GH secretagogues. ## Which Option Fits Your Goals? Consider these distinctions when discussing options with your provider: - **Sleep quality and pulsatile GH:** Sermorelin, administered at bedtime, best aligns with how your body naturally releases GH during sleep. Growth hormone secretagogue stacks like [CJC-1295 + Ipamorelin](https://www.telosrx.com/blogs/peptides/cjc-1295-ipamorelin-growth-hormone-stack-research) work through similar GHRH/ghrelin combination mechanisms. - **No injections:** MK-677 is the only oral option in this class. If injection is a firm barrier, it's the practical choice. - **Appetite is a concern:** If you're managing weight alongside GH optimization, sermorelin is preferable. MK-677's ghrelin-mimetic appetite increase is real and consistent. - **Body composition focus:** Both improve body composition over months. MK-677 may produce higher sustained IGF-1, which some protocols prioritize for lean mass. All of the above is subject to evaluation by a licensed provider. TelosRX's asynchronous intake lets you submit your health history and goals; a provider reviews and responds without requiring a live appointment. Compounded peptides are not FDA-approved. ## Frequently Asked Questions ### What is the main difference between sermorelin and MK-677? Sermorelin is an injectable peptide that mimics GHRH, triggering pulsatile GH release that follows your natural circadian rhythm. MK-677 is an oral, non-peptide compound that mimics ghrelin, producing a more sustained GH elevation over 24 hours. The practical difference is injection vs. oral dosing, and pulsatile vs. sustained GH pattern. ### Is sermorelin or MK-677 better for sleep quality? Sermorelin is generally preferred for sleep because its pulsatile GH release aligns with the natural GH peak during deep slow-wave sleep. MK-677 does improve sleep for some people, particularly early in use, but its sustained 24-hour GH elevation is less matched to the body's physiological night-phase pattern. ### Can sermorelin and MK-677 be taken together? Some protocols stack GHRH analogs with ghrelin receptor agonists to amplify GH release through complementary pathways — similar to how CJC-1295 and Ipamorelin are combined. This should only be done under provider direction, as stacking increases both potential effects and monitoring requirements. Neither compound is FDA-approved. ### Is MK-677 a steroid? No. MK-677 is a growth hormone secretagogue — it stimulates your body's own GH production through the ghrelin receptor. It is not anabolic in the same mechanism as anabolic steroids, though it may indirectly improve body composition through GH and IGF-1 elevation over time. ### Does MK-677 make you hungry? Yes, typically. MK-677 mimics ghrelin — the hunger hormone — so increased appetite is an expected, consistent effect. For people targeting lean mass gain in a caloric surplus, this can be an advantage. For those with weight management goals, it is usually a significant drawback compared to sermorelin. ### Is sermorelin FDA-approved? Compounded sermorelin is not FDA-approved. It is prepared under federal compounding regulations and available only through a licensed prescriber following a patient evaluation. The original FDA-approved sermorelin acetate product (Geref) was withdrawn from the US market in 2008; compounded versions are available but carry different regulatory status. ### How long until you see results from sermorelin or MK-677? Sleep quality improvements are often the first noticeable change, typically within 4–6 weeks. Body composition changes — reduced body fat, improved lean mass — become more apparent after 3–6 months of consistent use. Results depend on dose, diet, lifestyle, and individual response. Individual results vary. ### Are there risks from elevated IGF-1 with MK-677 long-term? Sustained IGF-1 elevation raises theoretical concerns about cell proliferation in sensitive tissues, which is why IGF-1 monitoring is standard in responsible protocols. Long-term human safety data on MK-677 specifically is limited. Providers typically use the lowest dose that achieves treatment goals and monitor biomarkers regularly. _TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service._ Start your private evaluation at [TelosRX](https://telosrx.com). **Tags:** ghrh, growth-hormone, ibutamoren, mk-677, peptides, sermorelin --- > Source: [Telos RX](https://www.telosrx.com/blogs/peptides/sermorelin-vs-mk-677-comparison)